We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


DomaniCell Obtains Stem Cell Banking License

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DomaniCell Obtains Stem Cell Banking License "

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

DomaniCell, LLC has announced it has obtained a license to perform umbilical cord blood collection, processing, and storage from the New Jersey Department of Health and Senior Services.

DomaniCell is applying for similar licenses, where required, in States throughout the country as it launches its hospital-based family cord blood collection and storage service.

In addition to state-level licensure, DomaniCell's licensed program also includes a nationwide license from PharmaStem Therapeutics, Inc. to PharmaStem's patent portfolio for the storage and use of umbilical cord blood.

The nature of DomaniCell's license is exclusive and thus provides hospitals with unique protection from patent-infringement claims.

"Our license strategy allows DomaniCell to enter into relationships with hospital partners to develop their own cord blood stem cell banking program that is built on DomaniCell infrastructure and technology," states DomaniCell President Dennis Fallen.

"The response we have received to-date from discussions with hospitals across the country has been overwhelmingly positive."